Navigating the FDA’s High Seas of Foreign Supplier Verification Program (FSVP) Inspections
Navigating FDA’s Complex Regulation of Homeopathic and Ayurvedic Products
The U.S. Food and Drug Administration (FDA) has announced its new medical device user fees for fiscal year 2025, effective October 1, 2024, highlighting significant
The FDA and FTC recently issued warning letters to several companies involved in the sale of Delta-8 THC products in packaging mimicking popular national brands
The Magic of FDA Export Certificates Including New Requirements for Dairy Exports to India
